CJA
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Résumé de cet Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a scholarly reply
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miyabe, M.
Right arrow Articles by Toyooka, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miyabe, M.
Right arrow Articles by Toyooka, H.
Canadian Journal of Anesthesia 50:193-197 (2003)
© Canadian Anesthesiologists' Society, 2003

Neuroanesthesia and Intensive Care

Olprinone, a phosphodiesterase III inhibitor, does not affect hypoxia-induced pial arteriolar dilatation in rabbits

[L’olprinone, un inhibiteur de la phosphodiestérase III, n’a pas d’effet sur la dilatation artériolaire pie-mérienne chez les lapins]

Masayuki Miyabe, MD, Keiichi Tajima, MD, Hiroshi Takahashi, MD and Hidenori Toyooka, MD

From the Department of Anesthesiology Institute of Clinical Medicine University of Tsukuba, Tsukuba, Japan.

Address correspondence to: Dr. Masayuki Miyabe, Department of Anesthesiology, Institute of Clinical Medicine, University of Tsukuba, Tsukuba 305-8575, Japan. Phone: 81-298-53-3088; Fax: 81-298-53-3092; E-mail: miyabe{at}md.tsukuba.ac.jp

Purpose: Olprinone, a phosphodiesterase III inhibitor, is used for the treatment of heart failure or asthma. Such patients may suffer from hypoxia. However, the effect of olprinone on the cerebral vasodilator response to hypoxia remains unclear.

Methods: Rabbits were anesthetized and ventilated mechanically. The pial arteriolar diameter was determined using a cranial window and intravital microscopy. Hypoxia was induced twice in the same animal by reducing FIO2 to 0.1. The first episode was induced during an infusion of saline, and the second during an infusion of saline (saline group; n = 8) or olprinone (1 µg•kg-1•min-1, OLP1 group; n = 8 or 10 µg•kg-1•min-1, OLP10 group; n = 8). The pial arteriolar responses to hypoxia were recorded and compared between the two episodes of hypoxia in each group.

Results: Blood gas data in the first hypoxic challenge were identical to those in the second challenge in each group. Pial arteriolar diameter increased significantly during hypoxia. In arterioles between 50–100 µm diameter, first and second hypoxia-induced pial arteriolar dilatation in OLP1 were 13 ± 6% and 10 ± 7% respectively (P = 0.574 ) and those in OLP10 were 16 ± 6% and 15 ± 7% respectively (P = 0.606). In arterioles between 25–50 µm, the results were the same as in arterioles between 50–100 µm.

Conclusion: Olprinone does not affect the hypoxia-induced dilatation of pial arterioles in pentobarbital anesthetized rabbits.







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the Canadian Anesthesiologists' Society.